Mirvaso | Brimonidine Tartrate Gel while Breastfeeding
Modern medicine has evolved so much so that sooner or later every breastfeeding mother needs to take it in one form or other. Medication that is present in mothers blood will transfer into her breast milk to some extent. Most drugs do so at low levels and pose no real risk to infants but then there are some exceptions. In This post will discuss whether Mirvaso | Brimonidine Tartrate Gel is safe in breast-feeding or not.

What is Mirvaso | Brimonidine Tartrate Gel used for?


MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) erythema of rosacea in adults 18 years of age or older. MIRVASO (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older.(1)

Mirvaso | Brimonidine Tartrate Gel while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Mirvaso | Brimonidine Tartrate Gel safe for breastfeeding
Active ingredient in Mirvaso | Brimonidine Tartrate Gel is Brimonidine tartrate and based on our analysis of Brimonidine tartrate it appears that using Mirvaso | Brimonidine Tartrate Gel is safe in breastfeeding. Below is analysis of Brimonidine tartrate while breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers It is not known whether brimonidine tartrate is excreted in human milk, although in animal studies, brimonidine tartrate has been shown to be excreted in breast milk. Because of the potential for serious adverse reactions from MIRVASO topical gel in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Mirvaso | Brimonidine Tartrate Gel Breastfeeding Analsys


Brimonidine tartrate while Breastfeeding

Safe

CAS Number: 70359-46-5

Like most ophthalmologic compounds for topical use a low dose and poor absorption make it compatible with breastfeeding. Systemic absorption is minimal. There have not been problems except when a maternal overdose was absorbed.

Mirvaso | Brimonidine Tartrate Gel Breastfeeding Analsys - 2


Brimonidine tartrate while Breastfeeding

CAS Number: 59803-98-4

Limited information indicates that maternal use of brimonidine 0.2% ophthalmic drops do not adversely affect their nursing infants. To substantially diminish the amount of drug that reaches the breastmilk after using eye drops, place pressure over the tear duct by the corner of the eye for 1 minute or more, then remove the excess solution with an absorbent tissue. Topical brimonidine gel used to treat rosacea has not been studied during breastfeeding. It is unlikely that the topical gel would affect the breastfed infant, but the manufacturer states that it should not be used during nursing. Until more data are available, an alternative topical agent might be preferred

Is Mirvaso | Brimonidine Tartrate Gel safe while breastfeeding

I am nursing mother and I have already used Mirvaso | Brimonidine Tartrate Gel, what should I do?

As usage of Mirvaso | Brimonidine Tartrate Gel is mostly safe while breastfeeding hence there should not be any concern. In case of any change in behavior or health of your baby you should inform your health care provider about usage of Mirvaso | Brimonidine Tartrate Gel else no further action is required.


I am nursing mother and my doctor has suggested me to use Mirvaso | Brimonidine Tartrate Gel, is it safe?

Definitely, Mirvaso | Brimonidine Tartrate Gel is safe in lactation for baby. No wonder your doctor has recommended it.


If I am using Mirvaso | Brimonidine Tartrate Gel, will my baby need extra monitoring?

No extra baby monitoring required while mother is using Mirvaso | Brimonidine Tartrate Gel


Who can I talk to if I have questions about usage of Mirvaso | Brimonidine Tartrate Gel in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Lumify Redness Reliever Eye Drops | Brimonidine Tartrate Solution/ Drops
Alphagan P | Brimonidine Tartrate Solution/ Drops